DFFVX
Price
$29.24
Change
+$0.32 (+1.11%)
Updated
Apr 17 closing price
Net Assets
11.34B
UBVLX
Price
$74.11
Change
+$0.76 (+1.04%)
Updated
Apr 17 closing price
Net Assets
8.8B
Ad is loading...

DFFVX vs UBVLX

Header iconDFFVX vs UBVLX Comparison
Open Charts DFFVX vs UBVLXBanner chart's image
DFA US Targeted Value I
Price$29.24
Change+$0.32 (+1.11%)
VolumeN/A
Net Assets11.34B
Undiscovered Managers Behavioral Val L
Price$74.11
Change+$0.76 (+1.04%)
VolumeN/A
Net Assets8.8B
DFFVX vs UBVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFFVX vs. UBVLX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and UBVLX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 11.3B vs. UBVLX (8.8B). UBVLX pays higher dividends than DFFVX: UBVLX (1.90) vs DFFVX (1.63). DFFVX was incepted earlier than UBVLX: DFFVX (25 years) vs UBVLX (26 years). UBVLX (0.95) is less costly to investors than DFFVX (0.30). UBVLX is a more actively managed with annual turnover of: 27.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than UBVLX: DFFVX (0) vs UBVLX (3000000). DFFVX annual gain was more profitable for investors over the last year : -3.30 vs. UBVLX (-4.49). DFFVX (105.39) and UBVLX (102.80) have equivalent 5 years return.
DFFVXUBVLXDFFVX / UBVLX
Total Expense Ratio0.290.9032%
Annual Report Gross Expense Ratio0.300.9532%
Fund Existence25 years26 years-
Gain YTD-14.553-11.879123%
Front LoadN/AN/A-
Min. Initial Investment03000000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.3B8.8B128%
Annual Yield % from dividends1.631.9086%
Returns for 1 year-3.30-4.4973%
Returns for 3 years1.74-9.86-18%
Returns for 5 years105.39102.80103%
Returns for 10 years33.7039.8485%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETIHX29.460.40
+1.38%
Eventide Healthcare & Life Sciences I
FMVQX49.500.52
+1.06%
Nuveen Mid Cap Value 1 R6
HAOYX20.000.17
+0.86%
Hartford International Opportunities Y
QSERX15.070.10
+0.67%
AQR Small Cap Multi-Style R6
CNPFX57.250.30
+0.53%
American Funds New Perspective 529F